Nečistoty aminokyseliny používané pro syntetizující protein
Detail produktu
| NO | Produkty | CAS Ne | Klíčový ukazatel kvality | |||
| Čistota | Max. nečistota | Celkové zbytky rozpouštědla | Vlhkost | |||
| 1 | FMOC-P-ALA-ALA-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 2 | FMOC-D-ALA-D-ALA-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 3 | FMOC-P-ALA-D-ALA-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 4 | FMOC-ARG (PBF) -ARG (PBF) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 5 | FMOC-P-ALA-ARG (PBF) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 6 | FMOC-D-ARG (PBF) -D-ARG (PBF) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 7 | FMOC-P-ALA-D-ARG (PBF) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 8 | FMOC-homoarg (PBF) -HOMOARG (PBF) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 9 | FMOC-P-ALA-homoarg (PBF) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 10 | Fmoc-asn (TRT) -Asn (TRT) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 11 | FMOC-P-ALA-ASN (TRT) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 12 | FMOC-ASP (OTBU) -ASP (OTBU) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 13 | FMOC-P-ALA-ASP (OTBU) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 14 | FMOC-CYS (TRT) -CYS (TRT) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 15 | FMOC-P-ALA-CYS (TRT) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 16 | FMOC-CYS (ACM) -CYS (ACM) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 17 | FMOC-P-ALA-CYS (ACM) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 18 | FMoc-Gln (TRT) -gln (TRT) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 19 | FMOC-P-ALA-GLN (TRT) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 20 | Fmoc-glu (Otbu) -glu (Otbu) -oh | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 21 | FMOC-P-ALA-GLU (OTBU) -OH.H2O | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 22 | FMOC-P-ALA-GLY-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 23 | Fmoc-his (TRT) -His (TRT) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 24 | FMOC-P-ALA-HIS (TRT) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 25 | Fmoc-ile-ile-Oh | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 26 | FMOC-P-ALA-ILE-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 27 | FMOC-LEU-LEU-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 28 | FMOC-P-ALA-LEU-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 29 | FMOC-D-LEU-D-LEU-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 30 | FMOC-P-ALA-D-LEU-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 31 | Fmoc-lys (BOC) -lys (BOC) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 32 | FMOC-P-ALA-lys (BOC) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 33 | Fmoc-lys (alloc) -lys (alloc) -oh | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 34 | FMOC-P-ALA-lys (Alloc) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 35 | FMOC-Met-Met-Oh | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 36 | FMOC-P-ALA-Met-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 37 | FMOC-ORN (BOC) -ORN (BOC) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 38 | FMOC-P-ALA-ORN (BOC) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 39 | FMOC-PHE-PHE-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 40 | FMOC-P-ALA-PHE-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 41 | FMOC-D-PHE-D-PHE-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 42 | FMOC-P-ALA-D-PHE-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 43 | FMOC-PRO-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 44 | FMOC-P-ALA-PRO-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 45 | FMOC-SER (TBU) -SER (TBU) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 46 | FMOC-P-ALA-SER (TBU) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 47 | FMOC-SER (TRT) -SER (TRT) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 48 | FMOC-P-ALA-SER (TRT) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 49 | FMOC-Ttr (TBU) -THR (TBU) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 50 | FMOC-P-ALA-Ttr (TBU) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 51 | FMOC-TRP (BOC) -TRP (BOC) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 52 | FMOC-P-ALA-TRP (BOC) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 53 | FMOC-D-TRP (BOC) -D-TRP (BOC) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 54 | FMOC-P-ALA-D-TRP (BOC) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 55 | FMOC-Tyr (TBU) -Tyr (TBU) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 56 | FMOC-P-ALA-Tyr (TBU) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 57 | FMOC-D-Tyr (ET) -D-Tyr (ET) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 58 | FMOC-P-ALA-D-Tyr (ET) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 59 | Fmoc-tyr (me) -tyr (me) -oh | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 60 | FMOC-P-ALA-Tyr (ME) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 61 | FMOC-VAL-VAL-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 62 | FMOC-P-ALA-VAL-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 63 | FMOC-D-CIT-D-CIT-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 64 | FMOC-P-ALA-D-CIT-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 65 | FMOC-P-ALA-DAB-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 66 | Fmoc- (3- (2-naftyl) -d-ala) 2-Oh | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 67 | FMOC-P-ALA-3- (2-naftyl) -d-Ala-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 68 | Fmoc- (3- (3-pyridinyl) -d-ala) 2-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 69 | FMOC-P-ALA-3- (3-Pyridinyl) -d-Ala-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 70 | Fmoc- (4-chlor-d-phe) 2-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 71 | FMOC-P-ALA-4-Chloro-D-PHE-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 72 | FMOC- (D-4APH (TBUCBM)) 2-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 73 | FMOC-P-ALA-D-4APH (TBUCBM) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 74 | FMOC-APH (L-HOR) -Aph (L-HOR) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 75 | FMOC-P-ALA-APH (L-HOR) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 76 | Fmoc-lys (IPR, BOC) -lys (IPR, BOC) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 77 | FMOC-P-ALA-lys (IPR, BOC) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 78 | FMOC-P-Ala-AEEA-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 79 | FMOC-AIB-AIB-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 80 | FMOC-P-ALA-AIB-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 81 | FMOC-ARG-OH | 91000-69-0 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 82 | H-ARG (PBF) -OH | 200115-86-2 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 83 | FMOC-D-ARG-OH | 130752-32-8 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 84 | HD-ARG (PBF) -OH | 200116-81-0 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 85 | FMOC-HOMOARG-OH.HCL | 208174-14-5 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 86 | H-Homoarg (PBF) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 87 | FMOC-D-HOMOARG-OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 88 | HD-homoarg (PBF) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 89 | FMOC-ASN-OH | 71989-16-7 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 90 | H-ASN (TRT) -OH | 132388-58-0 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 91 | FMOC-ASP-OH | 119062-05-4 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 92 | H-asp (Otbu) -oh | 3057-74-7 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 93 | Fmoc-Cys-Oh | 135248-89-4 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 94 | H-Cys (TRT) -OH | 2799/7/7 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 95 | H-Cys (ACM) -oh.hcl | 28798-28-9 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 96 | FMOC-GLN-OH | 71989-20-3 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 97 | H-GLN (TRT) -OH | 102747-84-2 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 98 | FMOC-GLU-OH | 121343-82-6 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 99 | H-glu (otbu) -oh.h2o | 2419-56-9 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 100 | FMOC-HIS-OH | 116611-64-4 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 101 | H-HIS (TRT) -OH | 35146-32-8 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 102 | Boc-his-oh | 17791-52-5 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 103 | FMOC-LYS-OH | 105047-45-8 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 104 | H-lys (BOC) -OH | 2418-95-3 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 105 | H-lys (alloc) -oh | 6298/3/9 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 106 | FMOC-ORN-OH.HCL | 201046-57-3 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 107 | H-ORN (BOC) -OH | 13650-49-2 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 108 | FMOC-SER-OH | 73724-45-5 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 109 | H-SER (TBU) -OH | 18822-58-7 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 110 | H-SER (TRT) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 111 | FMOC-Ttr-OH.H2O | 73731-37-0 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 112 | H-pokrm (TBU) -OH | 4378-13-6 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 113 | FMOC-TRP-OH | 35737-15-6 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 114 | H-Trp (BOC) -OH | 146645-63-8 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 115 | FMOC-D-TRP-OH | 86123-11-7 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 116 | HD-TRP (BOC) -OH | 201290-11-1 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 117 | Fmoc-Tyr-Oh | 92954-90-0 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 118 | H-Tyr (TBU) -OH | 18822-59-8 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 119 | FMOC-D-Tyr-Oh | 112883-29-1 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 120 | HD-Tyr (ET) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 121 | H-tyr (me) -oh.hcl | 67423-44-3 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 122 | FMOC-D-4APH (CBM) -OH | 324017-22-3 | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 123 | HD-4APH (TBUCBM) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 124 | FMOC-LYS (IPR) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
| 125 | H-lys (ipr, BOC) -OH | NA | ≥ 98,0% | ≤ 1,0% | ≤ 8,0% | ≤ 2,0% |
O
Kompenzace
Gentolex poskytuje kvalitní produkty, pokud je klient v požadovaném časovém rámci zvýšena kvalita produktu s dostatečnými důkazy, poskytneme nezbytnou analýzu a vyhodnocení, abychom spustili postupy kompenzací.
Výroba
Kapacity farmaceutických produktů dosáhly třídy tun, kapacity chemických produktů dosáhly 100tonů+ třídy, schopnosti jsou dobře vybaveny tak, aby sloužily klientům po celém světě.
Výzkum a vývoj
Každý rok se týmům výzkumu a vývoje zřídí plán na vývoj různých nových produktů, když cíle stanoví, každý člen v týmu bude muset pokračovat s odpovědností KPI a s motivační politikou.
